¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"skin erythema dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • source-skin distance
    ¿øÃµÇǺλçÀ̰Ÿ®, ¿øÃµÇǺΰ£°Å¸®
  • scalded skin syndrome
    È­»óÇǺÎÁõÈıº
  • split-thickness skin graft
    ºÎºÐÃþÇǺÎÀ̽Ä
  • staphylococcal scalded skin syndrome
    Æ÷µµ¾Ë±Õ¼º¿­»óÇǺÎÁõÈıº, Æ÷µµ±¸±Õ¼º¿­»óÇǺÎÁõÈıº
  • sailor¡¯s skin
    ¹î»ç¶÷ÇǺÎ
  • skin
    ÇǺÎ
  • skin appendage
    ÇǺκμӱâ(°ü)
  • skin care
    ÇǺΰü¸®
  • skin flap
    ÇÇºÎÆÇ, ÇÇÆÇ
  • skin flap blepharoplasty
    ÇÇºÎÆÇ´«²¨Ç®¼ºÇü(¼ú), ÇÇºÎÆÇ¾È°Ë¼ºÇü(¼ú)
  • skin flare
    ÇǺιßÀû
  • skin friction
    ÇǺθ¶Âû
  • skin graft
    1. ÇǺÎÀÌ½Ä 2. ÇǺÎÀÌ½ÄÆí
  • skin graft inlay
    ¼Ó³Ö±âÇǺÎÀ̽Ä, °¨ÀÔÇǺÎÀ̽Ä
  • skin lesion
    ÇǺκ´ÅÍ, ÇǺÎȯºÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • arterial skin flap
    µ¿¸ÆÇÇºÎÆÇ
  • artificial skin
    ÀΰøÇǺÎ
  • artificial skin graft
    ÀΰøÇǺÎÀ̽Ä
  • galvanic skin response audiometry
    ÇǺÎÀü±â¹ÝÀÀû·Â°Ë»ç
  • skin appendage
    ÇǺκμӱâ°ü, ÇǺκμӹ°
  • skin muscle approach
    ÇǺαÙÀ°Á¢±Ù¹ý
  • skin protective agent
    ÇǺκ¸È£Á¦
  • bronzed skin
    ûµ¿ÇǺÎ
  • skin flap blepharoplasty
    ÇÇºÎÆÇ´«²¨Ç®¼ºÇü(¼ú)
  • clammy skin
    ³Ã½ÀÇǺÎ
  • congestive skin
    ¿ïÇ÷ÇǺÎ
  • skin care
    ÇǺΰü¸®
  • dynamic skin line
    µ¿ÀûÇǺμ±
  • source-skin distance
    ¼±¿øÇǺΰ£°Å¸®
  • target skin distance
    Ç¥ÀûÇǺΰŸ®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • MTD=ÊÝmaximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • STD= standard test dose
    Ç¥ÁؽÃÇè·®.
  • absorbed dose
    Èí¼ö·®.¹æ»ç¼±Èí¼ö¼±·®(ýåâ¥àÊåÖ).
  • absorbed dose
    Èí¼ö¼±·®
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • acceptable daily dose : ADD
    ÀÏÀÏÇã¿ë·®(ìéìíúÉé»Õá).
  • acceptable dose
    ¿ëÀμ±·®, ¼ö¿ë¼±·®, Çã¿ë¼±·®
  • adult dosage =a. dose
    ¼ºÀη®, ¼ºÀο뷮.
  • arbitrary dose
    ÀÓÀǿ뷮(ìòëòéÄåÖ).
  • fractional dose
    ºÐÇÒ·®.
  • genetic tolerance dose
    À¯ÀüÀû ³»·®(¡­Ò±åÖ).
  • given dose
    ¸í¸ñ¼±·®
  • gonadal dose
    »ý½Ä¼±¼±·®
  • half lethal dose
    ¹ÝÄ¡»ç·®(ÚâöÈÞÝåÖ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • erythema iris<³ª>
    ȫä»ó(ûöóôßÒ)È«¹Ý
  • erythema marginatum
    À¯¿¬¼º È«¹Ý(êóæÞàõ ¡­)
  • erythema marginatum<³ª>
    À¯¿¬¼º(êóæÞàõ)È«¹Ý
  • erythema medicamentosum<³ª>
    ¾à¹°¼ºÈ«¹Ý
  • erythema migrans chronicum
    ¸¸¼º À¯ÁÖ¼º È«¹Ý
  • erythema migrans<³ª>
    À¯ÁÖ¼º(ë´ñËàõ) È«¹Ý
  • erythema morbilliform
    È«¿ª¾ç È«¹Ý
  • erythema multiforme
    ´ÙÇü(Òýû¡)È«¹Ý
  • erythema multiforme <³ª>
    ´Ù¹ß(¼º)È«¹Ý
  • erythema multiforme bullosum<³ª>
    ¼öÆ÷¼º(â©øÞàõ) ´ÙÇüÈ«¹Ý
  • erythema multiforme exudativum
    »ïÃ⼺ ´ÙÇü È«¹Ý
  • erythema multiforme<³ª>
    ´ÙÇü(Òýû¡)È«¹Ý
  • erythema nodosum
    °áÀý(Ì¿ï½)È«¹Ý
  • erythema nodosum = EN<³ª>
    °áÀý¼ºÈ«¹Ý
  • erythema nodosum leprosum
    ³ª¼º(ÑÛàõ)°áÀý È«¹Ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MPED minimum phototoxic erythema dose
TED Tasks of Emotional Development; threshold erythema dose; thromboembolic disease
SSA salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr...
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
JP drain The original suction drain. The drain itself is inside the body. It is made of Teflon and has multip...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
IPPSF isolated perfused porcine skin flap
LST Leishmanin skin test
LSE Living Skin Equivalent
MLS Microphthalmia with linear skin defects
NMSC Non Melanoma Skin Cancer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • dose-equivalent limit
    ¼±·® ´ç·® Çѵµ
  • dose-response curve
    ¿ë·® ¹ÝÀÀ °î¼±
  • dose-volume histogram
    ¼±·® üÀû È÷½ºÅä±×¶÷, ¼±·® üÀûÇ¥
  • effective dose 50%
    Áß°£ À¯È¿·®, 50% À¯È¿·®
    µ¿¹°¿¡ µ¶¼Ò³ª ¾à¹° Åõ¿© ½Ã, 50%ÀÇ µ¿¹°¿¡¼­ À¯È¿ÇÏ´Ù°í ÃßÁ¤µÇ´Â ¿ë·®.
  • equivalent dose
    µî°¡ ¼±·®
  • equivalent uniform dose
    µî°¡ ±ÕÁú ¼±·®
  • exposure dose
    Á¶»ç·®
  • high dose tolerance
    °í¿ª ¿ªÄ¡
  • immunizing dose
    ¸é¿ª·®
  • intoxicating dose
    Áßµ¶·®, Áßµ¶ ¼±·®
  • least fatal dose
    ÃÖ¼Ò Ä¡»ç·®
    ¾àÁ¦ÀÇ ¿ë·®À» °áÁ¤ÇÏ´Â ½ÇÇè¿¡¼­ 100¸í Áß 1¸íÀÌ¶óµµ »ç¸ÁÇÏ´Â ¹Ù·Î Á÷ÀüÀÇ ¿ë·®.
  • loading dose
    ºÎÇÏ ¿ë·®, ºÎÇÏ·®
  • maintenance dose
    À¯Áö·®, À¯Áö ¿ë·®
    ÀÏÁ¤ÇÑ »óŸ¦ À¯ÁöÇϱâ À§Çؼ­ ÇÊ¿äÇÑ ¾àÁ¦ÀÇ Åõ¿©·®.
  • maximal dose
    ÃÖ´ë ¿ë·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
erythema paratrimma Erythema due to stasis over pressure points.
(05 Mar 2000)
erythema pernio <symptom> Redness, itching and burning of the skin, especially the fingers, toes, heels, nose and ears on exposure to extreme cold and high humidity. Skin lesions may become blistered and or ulcerated.
(05 Jan 1998)
erythema perstans Probably a chronic form of erythema multiforme in which the relapses recur so persistently that the eruption is almost permanent.
(05 Mar 2000)
erythema polymorphe <dermatology> A rash that results from an allergic response, most often secondary to a drug. The rash is described as pink-red macules (flat), that may have clear centres (iris lesions) or appear as a dusky violet colour.
Erythema multiforme most often results from reactions to sulpha drugs, penicillin's, phenytoin, barbiturates, phenolphthalein and carbamazepine. In some cases, erythema multiforme can result secondary to a Herpes simplex infection or Mycoplasma infection.
(27 Sep 1997)
erythema simplex Blushing or redness of the skin caused by a toxic reaction or a neurovascular phenomenon.
Synonym: dermatitis simplex.
(05 Mar 2000)
erythema solare The burning or discolouration produced on the skin by the heat of the sun; tan.
Source: Websters Dictionary
(01 Mar 1998)
erythema threshold The amount of radiation that causes redness of the skin.
(09 Oct 1997)
erythema toxicum Flushing of the skin due to allergic reaction to some toxic substance.
(05 Mar 2000)
erythema toxicum neonatorum A common transient idiopathic eruption of erythema, small papules, and occasionally pustules filled with eosinophilic leukocytes overlying hair follicles of the newborn.
Synonym: erythema neonatorum.
(05 Mar 2000)
erythema tuberculatum Erythema multiforme in which the papules are of large size.
(05 Mar 2000)
Jacquet's erythema Colloquially referred to as diaper, ammonia, or napkin rash; dermatitis of thighs and buttocks resulting from exposure to urine and faeces in infants' diapers. Formerly attributed to ammonia formation; moisture, bacterial growth, and alkalinity may all induce lesions.
Synonym: ammonia rash, diaper rash, Jacquet's erythema, napkin rash.
(05 Mar 2000)
absorbed dose The amount of energy absorbed per unit mass of irradiated material at the target site; in radiation therapy, the former unit for absorbed dose is the rad; the current (S.I.) unit is the gray.
(05 Mar 2000)
air dose The radiation dose, expressed in roentgens, delivered at a point in free air.
Synonym: air dose.
(05 Mar 2000)
bone marrow dose The cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose.
(05 Mar 2000)
booster dose A dose given at some time after an initial dose to enhance the effect, said usually of antigens for the production of antibodies.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á